WHO WE ARE
The U.S. Army Medical Research and Development Command is the Army’s medical materiel developer, with responsibility for medical research, development and acquisition. The USAMRDC’s expertise in these critical areas helps establish and maintain the capabilities the Army needs to remain ready and lethal on the battlefield.
Ensuring our armed forces remain in optimal health and are equipped to protect themselves from disease and injury (particularly on the battlefield) is the job of the MRDC. The Command is headquartered at Fort Detrick, Maryland, with eight subordinate commands located throughout the world.
Six medical research laboratory commands execute the science and technology program to investigate medical solutions for the battlefield with a focus on various areas of biomedical research, including military infectious diseases, combat casualty care, military operational medicine, medical chemical and biological defense and clinical and rehabilitative medicine. The Command manages a large extramural research program with numerous contracts, grants and cooperative research and development agreements to provide additional science and technology capabilities from leading academic, private industry and other government organizations.
Two additional commands focus on medical materiel advanced development and medical research and development contracting.
The Command is staffed with highly qualified scientists, program managers, acquisition experts and support personnel. The critical expertise in these areas ensures we have the medical capabilities the Army needs to fight and win on the battlefield.
From illness to injury, the MRDC is the only organization solely focused on research and development to address the military’s unique medical readiness requirements.
Brigadier General Michael J. Talley
Commanding General of the U.S. Army Medical Research and Development Command
Michael J. Talley
Commanding General, U.S. Army Medical Research and Development Command
Brig. Gen. Michael J. Talley is the commanding general of the U.S. Army Medical Research and Development Command. He leads an Army organization focused on the research and development needed to address the military’s unique medical requirements.
Michael volunteered for military service in 1983. He achieved the rank of sergeant and was honorably discharged in 1989. He earned a Bachelor of Science degree from the University of Texas at El Paso and commissioned as a distinguished military graduate in 1991. His previous assignments include: Troop Commander, 3rd Armored Cavalry Regiment; Commander, 6th Medical Logistics Management Center; Assistant Deputy Chief of Staff G-3/5/7, Office of the Surgeon General & U.S. Army Medical Command; Commander, 44th Medical Brigade; U.S. Army Forces Command Surgeon; and Deputy Commanding General, Regional Health Command – Atlantic. He holds two Master of Military Arts and Sciences degrees: a Master of Strategic Studies degree from the Army War College and a Master of Arts degree from Webster University.
Command Sgt. Maj. Tim J. Sprunger
Commanding Sergeant Major of the U.S. Army Medical Research and Development Command
Command Sergeant Major Timothy J. Sprunger
Command Sergeant Major, U.S. Army Medical Research and Development Command
Command Sgt. Maj. Timothy J. Sprunger is the command sergeant major of the U.S. Army Medical Research and Development Command. In this role, he serves as a trusted advisor to the commander and the staff of a worldwide command leading the advancement of military medicine.
Tim enlisted as a medical specialist and attended basic combat training at Fort Knox, Kentucky, and later advanced individual training at Fort Sam Houston, Texas. He holds a Bachelor of Science in health education and a certificate in emergency and disaster management from Trident University International. His military career includes assignments at Fort Bragg, North Carolina; Fort Drum, New York; Fort Kobbe, Republic of Panama; and Landstuhl Regional Medical Center in Landstuhl, Germany. He has deployed in support of Operation Iraqi Freedom I and Operation Enduring Freedom VII.